Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
Treatment for diabetes and obesity is rapidly evolving, with multi-targeted approaches taking shape. Medications like semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, have set high benchmarks for weight loss and blood sugar management. Now, researchers are exploring compounds that work on several biological pathways simultaneously. Researchers have developed a groundbreaking ‘five-in-one’ experimental compound that has…
